SCHEMBL2967968

SCHEMBL2967968

[c]1sc2ccccc2c1-c1ccc2ccccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
ALOX5 P09917 1/20 0.38
CYP1A2 P05177 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
AR P10275 1/20 0.37
MAPT P10636 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6750072 0.79 DYRK1A (0.42) CA2GPR84
SCHEMBL21295742 0.71 NOTUM (0.40) CYP1A2SMN1; SMN2ALDH1A1CYP2C9HPGD
SCHEMBL2966653 0.71 KDM4E (0.35) CYP1A2SMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL2967965 0.69 GSTP1 (0.39) GSTP1ESR1ESR2ALOX5CYP1A2
SCHEMBL2046968 0.69 NPC1 (0.42) ALOX5CYP1A2SMN1; SMN2ALDH1A1HPGD
SCHEMBL1965942 0.69 RAB9A (0.46) ESR1CYP1A2SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL8175449 0.69 WDR5 (0.49) ALDH1A1HPGD
SCHEMBL1274645 0.68 ALOX5 (0.44) GSTP1ESR1ESR2ALOX5CYP1A2
SCHEMBL147192 0.68 LIMK1 (0.38) ESR1ESR2ALOX5ALDH1A1HPGD
SCHEMBL18086205 0.68 GPR3 (0.52) GSTP1ESR1ESR2ALOX5CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same TRPV3, TRPC3, HVCN1 GSTP1 2969/4885ESR1 1031/4885ESR2 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.